A Highly Sensitive Enzyme-Linked Immunosorbent Assay for the Determination of Tacrolimus in Atopic Dermatitis Patients
- 1 February 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 19 (1) , 88-91
- https://doi.org/10.1097/00007691-199702000-00016
Abstract
A highly sensitive enzyme-linked immunosorbent assay method has been developed for the determination of tacrolimus in human blood samples. The assay is a modification of the previously published assay with improved sensitivity. Following extraction of tacrolimus with methanol and sulfosalicylic acid, the samples are incubated for 2 h at room temperature on a Nunc Maxisorb plate that has been treated for nonspecific binding by precoating with polyclonal antibody. The analysis of human blood following the standard addition of tacrolimus (0.02-5.0 ng/ml) demonstrated excellent precision and accuracy over a 6-day period. The interday and intraday coefficients of variation were 6.0-28.9 and 3.9-15.2%, respectively. The limit of quantitation was 0.05 ng/ml. The method was used to quantitate blood concentration of tacrolimus in patients following the administration of tacrolimus ointment.Keywords
This publication has 4 references indexed in Scilit:
- Validation and Quality Assurance Program for Monitoring Tacrolimus (FK 506) Concentrations in Plasma and Whole BloodTherapeutic Drug Monitoring, 1993
- TacrolimusDrugs, 1993
- FK 506: a novel immunosuppressant for treatment of autoimmune diseaseSpringer Seminars in Immunopathology, 1993
- Immunosuppressive Macrolides of the Type FK 506: A Novel Class of Topical Agents for Treatment of Skin Diseases?Journal of Investigative Dermatology, 1992